Cukierman, Daphne Schneider <br/><br/>
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies.  [electronic resource] 

 -  Journal of inorganic biochemistry  05 2017 
 - 160-168 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3344 
<br/><br/><label>Standard No.: </label>10.1016/j.jinorgbio.2017.02.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood-Brain Barrier--metabolism<br/>Chelating Agents--chemical synthesis<br/>Drug Evaluation, Preclinical<br/>Hydrazones--chemical synthesis<br/>Male<br/>Parkinson Disease, Secondary--drug therapy<br/>Rats<br/>Rats, Wistar